NCT07417475Completed
Robot-Assisted Radical Prostatectomy: the HOOD Technique Versus Standard Anterior Reconstruction
Early Functional Outcomes After Robot-Assisted Radical Prostatectomy: A Prospective Comparison of the HOOD Technique Versus Standard Anterior Reconstruction
Source: ClinicalTrials.gov · Last updated 18 Feb 2026
Brief summary (registry, in English)
This prospective, non-randomized cohort study included consecutive patients undergoing robotic-assisted laparoscopic radical prostatectomy (RARP) between January 2024 and January 2026 following ethics committee approval. Patients with clinically localized prostate cancer eligible for bilateral nerve-sparing surgery were enrolled. Two surgical techniques-anterior-posterior reconstruction (APR) and the HOOD technique-were compared. All procedures were performed by a single high-volume surgeon at a tertiary referral center. The primary endpoint was early urinary continence recovery, assessed at catheter removal and at 3, 6, and 12 weeks postoperatively. Secondary outcomes included postoperative complications, positive surgical margin rates, and early oncological outcomes.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 200 (actual)
- First submitted
- 11 Feb 2026
- Start date
- 1 Jan 2024
- Primary completion date
- 1 Jan 2026
- Lead sponsor
- Araz Musaev
- Diseases
- Prostate cancer
- NCT number
- NCT07417475
What you commit to
- Study type: Interventional
- Participants enrolled: 200
- From 1 Jan 2024 to the primary completion date, 1 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- previous prostatic, urethral, bladder neck surgery
- neoadjuvant therapy
- prior pelvic radiotherapy
Other illness
- high risk prosatate cancer
- M1 prostate cancer (according to preoperative GA68 PSMA PET CT)
Other
- cN1
- pre-existing urinary incontinence,
Who the study is looking for
- life expectancy \>10 years,
- clinically organ confined disease (cT1-cT2),
- biopsy ISUP GG ≤3,
- total serum prostate-specific antigen (PSA) ≤10 ng/ml
- normal preoperative continence and potency
Age in the registry: 40 years to 75 years · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ankara Universtity School of medicine department of urology Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.